Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hip Dislocation or Femur Head Necrosis
and you are
between 18 and 24
years old
The phase for this study is not defined.
Show me locations

The purpose

Although older children and high dislocations may be more likely to require a femoral shortening osteotomy, the ultimate decision about whether or not to shorten a given femur should depend on the ease of femoral head reduction in that specific patient. Adding a femoral shortening procedure increases operating time and blood loss, adds a second incision, and necessitates future hardware removal. In addition, an unnecessary femoral shortening osteotomy could overly decrease the soft tissue tension around the joint, putting the hip at risk for redislocation. This study was designed to explore an algorithm based on strict age and radiographic criteria that identify those without the need of femoral osteotomy.

Provided treatments

  • Procedure: Osteotomy
  • Procedure: Non-osteotomy
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02633904. The sponsor of the trial is He Jin Peng and it is looking for 200 volunteers for the current phase.
Official trial title:
Investigation of the Value of Femoral Shortening Osteotomy During Open Treatment of Developmental Dislocation of the Hip in Waliking Age Group